Mark A. Atkinson
Affiliations: | University of Florida, Gainesville, Gainesville, FL, United States |
Area:
Immunology, EpidemiologyGoogle:
"Mark Atkinson"
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
F De Jesus D, Zhang Z, Brown NK, et al. (2024) Redox regulation of mA methyltransferase METTL3 in β-cells controls the innate immune response in type 1 diabetes. Nature Cell Biology |
Foster TP, Jacobsen LM, Bruggeman B, et al. (2023) Low-Dose Antithymocyte Globulin: A Pragmatic Approach to Treating Stage 2 Type 1 Diabetes. Diabetes Care |
Beran D, Koch M, Ajmal S, et al. (2023) The Lancet Diabetes & Endocrinology Commission on type 1 diabetes: looking back to move forward. The Lancet. Diabetes & Endocrinology |
Redondo MJ, Harrall KK, Glueck DH, et al. (2023) Diabetes Study of Children of Diverse Ethnicity and Race: Study design. Diabetes/Metabolism Research and Reviews. e3744 |
Shapiro MR, Dong X, Perry DJ, et al. (2023) Human immune phenotyping reveals accelerated aging in type 1 diabetes. Jci Insight |
Atkinson MA, Mirmira RG. (2023) The pathogenic "symphony" in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas. Cell Metabolism |
Matsumoto R, Gray J, Rybkina K, et al. (2023) Induction of bronchus-associated lymphoid tissue is an early life adaptation for promoting human B cell immunity. Nature Immunology |
Jacobsen LM, Diggins K, Blanchfield L, et al. (2023) Responders to low-dose ATG induce CD4 T cell exhaustion in type 1 diabetes. Jci Insight |
Connors TJ, Matsumoto R, Verma S, et al. (2023) Site-specific development and progressive maturation of human tissue-resident memory T cells over infancy and childhood. Immunity |
Jung S, Nasr MB, Bahmani B, et al. (2023) Nano-Targeted Delivery of Immune Therapeutics in type 1 Diabetes. Advanced Materials (Deerfield Beach, Fla.). e2300812 |